Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity

Aim. To investigate differential beta-adrenoblocker (BAB) therapy, based on clinical and demographic characteristics of the patients, as a method to optimise the management of chronic heart failure (CHF).Material and methods. The study included 90 patients: 50 men (55,6%) and 40 women (44,4%) of mea...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	S. N. Tereshchenko, I. V. Zhirov, A. V. Akinina, A. G. Kochetov
Fformat:	Artigo
Iaith:	Russo
Cyhoeddwyd:	«SILICEA-POLIGRAF» LLC 2009-10-01
Cyfres:	Кардиоваскулярная терапия и профилактика
Pynciau:	chronic heart failure beta-adrenoblockers brain natriuretic peptide aldosterone noradrenalin
Mynediad Ar-lein:	https://cardiovascular.elpub.ru/jour/article/view/1855
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!